Anthrax Pipeline Highlights – 2017 Update

1. Anthrax Pipeline by Stages

2. Anthrax Pipeline by Drug Class

3. Anthrax Pipeline by Company

4. Anthrax Phase 3 Clinical Trial Insights

5. Anthrax Phase 2 Clinical Trial Insights

6. Anthrax Phase 1 Clinical Trial Insights

7. Anthrax Preclinical Research Insights

8. Anthrax Discovery Stage Insights

9. Appendix

10. Research Methodology

LIST OF TABLES

Table 1: Anthrax Phase 3 Clinical Trials, 2017

Table 2: Anthrax Phase 2 Clinical Trials, 2017

Table 3: Anthrax Phase 1 Clinical Trials, 2017

Table 4: Anthrax Preclinical Research, 2017

Table 5: Anthrax Discovery Stage, 2017

LIST OF FIGURES

Figure 1: Anthrax Pipeline Molecules by Clinical Trials Stage, 2017

Figure 2: Anthrax Pipeline Molecules by Drug Class, 2017

Figure 3: Anthrax Pipeline Molecules by Company, 2017

Figure 4: Anthrax Phase 3 Clinical Trial Highlights, 2017

Figure 5: Anthrax Phase 2 Clinical Trial Highlights, 2017

Figure 6: Anthrax Phase 1 Clinical Trial Highlights, 2017

Figure 7: Anthrax Preclinical Research Highlights, 2017

Figure 8: Anthrax Discovery Stage Highlights, 2017

Anthrax Pipeline Highlights – 2017 Update

The latest report from Fore Pharma, Anthrax Pipeline Highlights – 2017 Update, provides most up-to-date information on key pipeline products in the global Anthrax market. It covers emerging therapies for Anthrax in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:
The report provides Anthrax pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:
The report provides Anthrax pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:
The report provides Anthrax pipeline products by the company.

Short-term Launch Highlights:
Find out which Anthrax pipeline products will be launched in the US and Ex-US till 2020.

SUMMARY:

• Anthrax phase 3 clinical trial pipeline products
• Anthrax phase 2 clinical trial pipeline products
• Anthrax phase 1 clinical trial pipeline products
• Anthrax preclinical research pipeline products
• Anthrax discovery stage pipeline products
• Anthrax pipeline products short-term launch highlights